Sign in
4

Changes in Ownership

Xilio Therapeutics, Inc. Filed Acc 0001193125-26-412466

Options or other derivatives

  • CHIEF MEDICAL OFFICER acquired 105,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Houvras Yariv · CHIEF MEDICAL OFFICER

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-10-01 Grant or award : show line 1 in the form Stock Option (right to buy) +105,000 105,000 D
Loading xslF345X06/ownership.xml…